IPercept invests in Isogon Ventures
Funding Provisional 90% confidence first seen
Swedish machine fitness tracker startup IPercept raised a $16.5M Series A round that was co-led by Isogon Ventures and 2150, with participation from investors including Luminar Ventures, RunwayFBU, J12 Venture, and AI.Fund. The reported use of funds includes launching in the US with initial local hires and improving its AI technology for predictive maintenance of CNC machines. This matters as it expands Isogon Ventures’ exposure to industrial AI and supports IPercept’s scaling of its machine-wear monitoring platform used by major manufacturers such as Airbus, Bosch, and Volvo.
The deal
IPercept $16.5M Series A · announced 29 Sep 2026
Investors Isogon Ventures 2150 Luminar Ventures RunwayFBU J12 Venture AI.Fund
Deal terms as reported in the coverage below.
Decision brief
- What changed
- IPercept, a Swedish startup focused on predictive maintenance for CNC machines, raised a $16.5 million Series A round co-led by Isogon Ventures and 2150. The company said it will use the funding to launch in the US with initial local hires and to further improve its AI technology.
- Why it matters
- For business leaders in industrial AI and manufacturing technology, this financing signals fresh investor backing behind AI-based machine-wear monitoring for CNC equipment. The planned US launch and product investment suggest IPercept is moving from proof of use toward broader commercial scaling, which could increase competition for industrial analytics vendors and expand buyer awareness in predictive maintenance.
- Evidence
- The coverage comes from a single Tech.eu report stating that IPercept raised $16.5 million in a Series A co-led by Isogon Ventures and 2150, with named participating investors. The same report says the funds will support a US launch, initial hires, and further development of AI technology already used by Airbus, Bosch, and Volvo.
- What remains uncertain
- The report does not disclose valuation, ownership stakes, revenue, customer contract scope, or deployment scale at Airbus, Bosch, and Volvo, so the commercial strength of the business is unclear. It also does not verify timing or execution details for the US expansion, so assumptions about near-term market impact remain unconfirmed.
- Monitor next
- Watch for IPercept’s first announced US hires, customer wins, or partnerships that confirm execution of its stated expansion plan.
Analytical support, not advice — assumptions and open questions stated above.